Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS)

CUSIP: 00509G209

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
71,531,081
Total 13F shares
43,186,479
Share change
+17,196,296
Total reported value
$179,213,677
Put/Call ratio
112%
Price per share
$4.15
Number of holders
64
Value change
+$71,103,757
Number of buys
47
Number of sells
21

Quarterly Holders Quick Answers

What is CUSIP 00509G209?
CUSIP 00509G209 identifies ABOS - Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS) as of Q3 2023

As of 30 Sep 2023, Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS) was held by 64 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,186,479 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Sands Capital Ventures, LLC, FRANKLIN RESOURCES INC, Rock Springs Capital Management LP, Deep Track Capital, LP, Boxer Capital, LLC, Laurion Capital Management LP, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, and Knollwood Investment Advisory, LLC. This page lists 64 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.